>Europäischer Markt für Frauengesundheitsdiagnostik nach Anwendung (Brustkrebstests, Gebärmutterhalskrebstests, Schwangerschafts- und Fruchtbarkeitstests, Eierstockkrebstests, Tests auf Infektionskrankheiten , Ultraschalltests, Tests auf sexuell übertragbare Krankheiten und andere), Tests (Biopsien, andere Brustkrebstests, Schwangerschafts- und Fruchtbarkeitstests, Labortests, Schwangerschaftstests und Eisprungvorhersage-Kits, Fruchtbarkeitsmonitore, pränatales genetisches Screening und Trägertests, CF-Tests, Tests auf Down-Syndrom und Edwards-Syndrom, TORCH-Tests, andere pränatale Tests auf genetische Krankheiten, Tests auf Infektionskrankheiten, MRSA-Tests, Harnwegsinfektionstests, Hepatitis-Tests) und nach Endbenutzer (Diagnose- und Bildgebungszentren, Krankenhäuser und Kliniken sowie häusliche Pflege) – Branchentrends und Prognose bis 2029
Marktanalyse und Größe
Laut Weltgesundheitsorganisation leben in der Europäischen Region über 470 Millionen Frauen, was etwas mehr als der Hälfte der Gesamtbevölkerung entspricht. Um die demografischen und epidemiologischen Veränderungen in dieser vielfältigen Region, wie Alterung und Migration, zu verstehen, muss man sich mit der Gesundheit von Frauen auskennen. Darüber hinaus betrug das BIP der Europäischen Union im Jahr 2018 laut Weltbank rund 18,8 Billionen USD, und die Gesundheitsausgaben sind nach den Sozialausgaben der zweitgrößte Posten der öffentlichen Ausgaben. Die gesamten Gesundheitsausgaben der Bundesregierung betrugen 9,6 Prozent des BIP. Dies wird die Gesundheitsinfrastruktur und die Anzahl klinischer Labore und Diagnoseeinrichtungen in Europa erhöhen und den Markt für Frauengesundheitsdiagnostik im kommenden Jahr ankurbeln.
Data Bridge Market Research analysiert, dass der Markt für Frauengesundheitsdiagnostik, der im Jahr 2021 26,48 Milliarden USD betrug, bis 2029 auf 41,88 Milliarden USD anwachsen wird und im Prognosezeitraum 2022–2029 eine durchschnittliche jährliche Wachstumsrate von 5,9 % aufweisen wird. Der vom Data Bridge Market Research-Team zusammengestellte Marktbericht umfasst eine eingehende Expertenanalyse, Patientenepidemiologie, Pipeline-Analyse, Preisanalyse und regulatorische Rahmenbedingungen.
Marktdefinition
Frauengesundheit bezieht sich auf die Diagnose und Behandlung von Krankheiten und Leiden, die das körperliche und geistige Wohlbefinden einer Frau beeinträchtigen können. Frauengesundheit umfasst Empfängnisverhütung, sexuell übertragbare Infektionen (STIs), gynäkologische Erkrankungen, Brustkrebs, Eierstockkrebs, andere Krebsarten bei Frauen, Wechseljahre, Hormontherapie, Osteoporose, Schwangerschaft und Geburt, sexuelle Gesundheit, Frauen und Herzkrankheiten sowie gutartige Erkrankungen, die die Funktion der weiblichen Fortpflanzungsorgane beeinträchtigen.
Berichtsumfang und Marktsegmentierung
|
Berichtsmetrik |
Details |
|
Prognosezeitraum |
2022 bis 2029 |
|
Basisjahr |
2021 |
|
Historische Jahre |
2020 (Anpassbar auf 2019 – 2014) |
|
Quantitative Einheiten |
Umsatz in Mrd. USD, Volumen in Einheiten, Preise in USD |
|
Abgedeckte Segmente |
Anwendung (Tests auf Brustkrebs, Gebärmutterhalskrebs, Schwangerschafts- und Fruchtbarkeitstests, Tests auf Eierstockkrebs, Tests auf Infektionskrankheiten, Ultraschalltests, Tests auf sexuell übertragbare Krankheiten und andere) und nach Endbenutzer (Diagnose- und Bildgebungszentren, Krankenhäuser und Kliniken sowie häusliche Pflege) |
|
Abgedeckte Länder |
USA, Kanada und Mexiko in Nordamerika, Deutschland, Frankreich, Großbritannien, Niederlande, Schweiz, Belgien, Russland, Italien, Spanien, Türkei, Restliches Europa in Europa |
|
Abgedeckte Marktteilnehmer |
Siemens (Deutschland), Hologic, Inc. (MA), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), Abbott (USA), BD (NJ), F. Hoffmann-La Roche Ltd (Schweiz), Thermo Fisher Scientific Inc. (USA), Koninklijke Philips NV (Niederlande), NeuroLogica Corp. (USA), Shimadzu Medical (Indien) pvt. Ltd. (Japan), GENERAL ELECTRIC (USA), Quest Diagnostics Incorporated (USA), Sysmex India Pvt. Ltd. (Japan), Hitachi, Ltd. (Japan), Canon Inc. (Japan), FUJIFILM Holdings Corporation (Großbritannien) |
|
Marktchancen |
|
Marktdynamik für Frauengesundheitsdiagnostik
Treiber
- Zunehmende Häufigkeit chronischer und lebensstilbedingter Erkrankungen
Die wachsende Zahl von Bildgebungs- und Diagnosezentren sowie der zunehmende Einsatz von Point-of-Care- und Schnelldiagnosetests. Da die Prävalenz von Arthrose, Eierstockkrebs, Brustkrebs und Gebärmutterhalskrebs steigt, wächst der Markt für Diagnostik im Bereich der Frauengesundheit. Brustkrebs ist die häufigste Krebserkrankung bei Frauen und die zweithäufigste Krebserkrankung weltweit. Im Jahr 2018 wurden fast 2 Millionen neue Fälle gemeldet.
- Anstieg der Zulassungsquote für Point-of-Care-Diagnostik
Der Markt dürfte wachsen, da die Zahl der weltweit verkauften Diagnose- und Bildgebungsgeräte steigt. Allerdings dürften eine steigende Nachfrage nach der Entwicklung von Miniaturdiagnosegeräten sowie ein Ausbau der Gesundheitsinfrastruktur und neue Marketinginitiativen wichtiger Anbieter in Schwellenländern im Prognosezeitraum 2022–2029 für eine Marktexpansion sorgen.
- Zunehmende Prävalenz von Arthrose, Eierstockkrebs, Brustkrebs und Gebärmutterhalskrebs
Brustkrebs ist die häufigste Krebserkrankung bei Frauen und die zweithäufigste Krebserkrankung weltweit. Laut Globocan 2020 werden im Jahr 2020 2.261.419 neue Fälle von Brustkrebs diagnostiziert. Die steigende Zahl der Fälle hat zu einem Anstieg der Verkäufe von Testkits für den Heimgebrauch geführt, was das Umsatzwachstum des Marktes im gesamten Prognosezeitraum ankurbeln dürfte. Die zunehmende Akzeptanz von Point-of-Care-Diagnosetests und eine Zunahme der weltweit verfügbaren Anzahl von Diagnose- und Bildgebungsgeräten werden den Markt voraussichtlich vorantreiben.
Gelegenheiten
Die steigende Prävalenz von Brustkrebs, höhere Forschungs- und Entwicklungsausgaben sowie Verbesserungen in der Krebsdiagnostik dürften die Expansion des Segments beschleunigen. Laut Globocan wurden im Jahr 2020 weltweit etwa 2,26 Millionen neue Fälle von Brustkrebs bei Frauen diagnostiziert, was etwa 11,7 Prozent aller Krebsfälle entspricht. Mit der Entwicklung des Patientenpools für Brustkrebs dürfte die Nachfrage nach Diagnostika noch schneller steigen. Produkteinführungen sind ein weiterer wichtiger Faktor für die Expansion des Marktes.
Einschränkungen/Herausforderungen
Der Markt für Diagnostikprodukte für die Frauengesundheit ist mit Problemen konfrontiert: Der Widerstand der Patienten gegen frühzeitige Vorsorgeuntersuchungen, deren Diagnose mit erheblichen Kosten verbunden ist, die Möglichkeit einer Überdiagnose und Überbehandlung sowie die Tatsache, dass MRT-Scans zwar genau sind, für die Patienten jedoch zeitaufwändig und teuer.
Diagnostische Tests für die Gesundheit von Frauen sind kostspielig, was eine erhebliche Markteintrittsbarriere darstellt. Der Sektor der Diagnostik für die Gesundheit von Frauen steht vor erheblichen Herausforderungen, da es an Informationen über verschiedene Krankheiten und Diagnosemethoden mangelt. Unternehmen mit niedrigem Einkommen und Schwellenländer befassen sich mit Marktbeschränkungen in der Diagnostik für die Gesundheit von Frauen.
Dieser Marktbericht zur Diagnostik für die Gesundheit von Frauen enthält Einzelheiten zu neuen Entwicklungen, Handelsvorschriften, Import-Export-Analysen, Produktionsanalysen, Optimierung der Wertschöpfungskette, Marktanteilen, Auswirkungen inländischer und lokaler Marktteilnehmer, analysiert Chancen in Bezug auf neue Einnahmequellen, Änderungen der Marktvorschriften, strategische Marktwachstumsanalysen, Marktgröße, Kategoriemarktwachstum, Anwendungsnischen und -dominanz, Produktzulassungen, Produkteinführungen, geografische Expansionen und technologische Innovationen auf dem Markt. Um weitere Informationen zum Markt für Diagnostik für die Gesundheit von Frauen zu erhalten, wenden Sie sich an Data Bridge Market Research, um ein Analyst Briefing zu erhalten. Unser Team hilft Ihnen dabei, eine fundierte Marktentscheidung zu treffen, um Marktwachstum zu erzielen.
Auswirkungen von COVID-19 auf den Markt für Frauengesundheitsdiagnostik
Aufgrund der Unsicherheit auf den Kapitalmärkten und in der Weltwirtschaft führten begrenzte Transitmöglichkeiten und Reisebeschränkungen während der COVID-19-Pandemie zu Hindernissen im internationalen Handel und Transport, was sich auf die Lieferkette für Diagnostika für die Frauengesundheit auswirkte und die Nachfrage vorübergehend senkte. Der Fortschritt dieser Branche wird durch ungünstige Änderungen von Regeln und Gesetzen behindert. Laut großen Regulierungsorganisationen kommt es bei Brustkrebspatientinnen häufiger zu einer COVID-19-Infektion als bei gesunden Menschen. Screenings, chirurgische Eingriffe und diagnostische Untersuchungen in Krankenhäusern und Brustkrebskliniken wurden infolgedessen verschoben oder stark eingeschränkt.
Jüngste Entwicklung
- Roche gab im Mai 2019 bekannt, dass der VENTANA HER2 Dual ISH DNA Probe Cocktail-Test zum Nachweis des HER2-Biomarkers bei Magen- und Brustkrebs verfügbar sein wird. Dies würde zur Erweiterung der Produktlinie des Unternehmens beitragen.
Umfang des europäischen Marktes für Frauengesundheitsdiagnostik
Der Markt für Frauengesundheitsdiagnostik ist nach Test, Anwendung und Endnutzer segmentiert. Das Wachstum dieser Segmente hilft Ihnen bei der Analyse schwacher Wachstumssegmente in den Branchen und bietet den Benutzern einen wertvollen Marktüberblick und Markteinblicke, die ihnen bei der strategischen Entscheidungsfindung zur Identifizierung der wichtigsten Marktanwendungen helfen.
Anwendung
- Osteoporose-Test
- Knochendichtemessung
- In-vitro-Bluttests
- OVC-Test
- OVC-Tumormarkertests
- OVC-Diagnosebildgebungstests
- Andere OVC-Tests
- Untersuchung auf Gebärmutterhalskrebs
- Pap-Abstrich
- HPV-Test
- Brustkrebs-Test
- Mammographie
Tests
- Biopsien
- Andere Brustkrebstests
- Schwangerschafts- und Fruchtbarkeitstests
- Laborbasierte Tests
- Schwangerschaftstests und Kits zur Eisprungvorhersage
- Fruchtbarkeitsmonitore
- Pränatales genetisches Screening und Trägertests
- CF-Test
- Tests auf Down-Syndrom und Edwards-Syndrom
- TORCH-Tests
- Andere pränatale Tests auf genetische Erkrankungen
- Tests auf Infektionskrankheiten
- MRSA-Test
- Harnwegsinfektionstests
- Hepatitis-Test
- Tuberkulose-Test
- Andere Tests auf Infektionskrankheiten
- STD-Tests
- CT/NG-Untersuchung
- HIV-Test
- Andere STD-Tests
- Ultraschalluntersuchungen
- Brustbildgebung
- Gynäkologische Bildgebung
Endbenutzer
- Krankenhäuser und Kliniken
- Diagnose- und Bildgebungszentren
- Einstellungen für die häusliche Pflege
Regionale Analyse/Einblicke zum Markt für Frauengesundheitsdiagnostik
Der Markt für Frauengesundheitsdiagnostik wird analysiert und es werden Einblicke in die Marktgröße und Trends nach Land, Test, Anwendung und Endbenutzer wie oben angegeben bereitgestellt.
Die im Marktbericht zur Frauengesundheitsdiagnostik abgedeckten Länder sind die USA, Kanada und Mexiko in Nordamerika, Deutschland, Frankreich, Großbritannien, Niederlande, Schweiz, Belgien, Russland, Italien, Spanien, Türkei, Restliches Europa in Europa, China, Japan, Indien, Südkorea, Singapur, Malaysia, Australien, Thailand, Indonesien, Philippinen, Restlicher Asien-Pazifik-Raum (APAC) in der Asien-Pazifik-Region (APAC), Saudi-Arabien, Vereinigte Arabische Emirate, Südafrika, Ägypten, Israel, Restlicher Naher Osten und Afrika (MEA) als Teil von Naher Osten und Afrika (MEA), Brasilien, Argentinien und Restliches Südamerika als Teil von Südamerika.
Angesichts der hohen Krebsrate bei Frauen, der steigenden Zahl lebensstilbedingter Erkrankungen, der hohen Akzeptanz technologisch fortschrittlicher Produkte, Produkteinführungen und Regierungsinitiativen wird erwartet, dass der Markt für Frauengesundheitsdiagnostik in Nordamerika und Europa stetig wachsen wird.
Durch verstärkte Kampagnen zu Gesundheitsthemen von Frauen und zur Aufklärung über Krankheiten konnte die Region Asien-Pazifik ihre Gesundheitssituation verbessern und sich zu einem wachsenden Teilnehmer auf dem Markt für Frauengesundheitsdiagnostik entwickeln.
Der Länderabschnitt des Berichts enthält auch Angaben zu einzelnen marktbeeinflussenden Faktoren und Änderungen der Regulierung auf dem Inlandsmarkt, die sich auf die aktuellen und zukünftigen Trends des Marktes auswirken. Datenpunkte wie Downstream- und Upstream-Wertschöpfungskettenanalysen, technische Trends und Porters Fünf-Kräfte-Analyse sowie Fallstudien sind einige der Anhaltspunkte, die zur Prognose des Marktszenarios für einzelne Länder verwendet werden. Bei der Bereitstellung von Prognoseanalysen der Länderdaten werden auch die Präsenz und Verfügbarkeit globaler Marken und ihre Herausforderungen aufgrund großer oder geringer Konkurrenz durch lokale und inländische Marken sowie die Auswirkungen inländischer Zölle und Handelsrouten berücksichtigt.
Wachstum der Gesundheitsinfrastruktur, installierte Basis und Durchdringung mit neuen Technologien
Der Markt für Frauengesundheitsdiagnostik bietet Ihnen außerdem detaillierte Marktanalysen für jedes Land, das Wachstum der Gesundheitsausgaben für Investitionsgüter, die installierte Basis verschiedener Arten von Produkten für den Markt für Frauengesundheitsdiagnostik, die Auswirkungen der Technologie anhand von Lebenslinienkurven und Änderungen der regulatorischen Szenarien im Gesundheitswesen und deren Auswirkungen auf den Markt für Frauengesundheitsdiagnostik. Die Daten sind für den historischen Zeitraum 2010–2020 verfügbar.
Wettbewerbsumfeld und Analyse der Marktanteile im Bereich Frauengesundheitsdiagnostik
Die Wettbewerbslandschaft auf dem Markt für Frauengesundheitsdiagnostik liefert Details nach Wettbewerbern. Die enthaltenen Details sind Unternehmensübersicht, Unternehmensfinanzen, erzielter Umsatz, Marktpotenzial, Investitionen in Forschung und Entwicklung, neue Marktinitiativen, globale Präsenz, Produktionsstandorte und -anlagen, Produktionskapazitäten, Stärken und Schwächen des Unternehmens, Produkteinführung, Produktbreite und -umfang, Anwendungsdominanz. Die oben angegebenen Datenpunkte beziehen sich nur auf den Fokus der Unternehmen in Bezug auf den Markt für Frauengesundheitsdiagnostik.
Zu den wichtigsten Akteuren auf dem Markt für Frauengesundheitsdiagnostik zählen:
- Siemens (Deutschland)
- Hologic, Inc. (MA)
- Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China)
- Abbott (USA)
- BD (NJ)
- F. Hoffmann-La Roche AG (Schweiz)
- Thermo Fisher Scientific Inc. (USA)
- Koninklijke Philips NV (Niederlande)
- NeuroLogica Corp. (USA)
- Shimadzu Medical (Indien) pvt. Ltd. (Japan)
- GENERAL ELECTRIC (USA)
- Quest Diagnostics Incorporated (USA)
- Sysmex India Pvt. Ltd. (Japan)
- (Japan)
- Canon Inc. (Japan)
- FUJIFILM Holdings Corporation (Großbritannien)
SKU-
Erhalten Sie Online-Zugriff auf den Bericht zur weltweit ersten Market Intelligence Cloud
- Interaktives Datenanalyse-Dashboard
- Unternehmensanalyse-Dashboard für Chancen mit hohem Wachstumspotenzial
- Zugriff für Research-Analysten für Anpassungen und Abfragen
- Konkurrenzanalyse mit interaktivem Dashboard
- Aktuelle Nachrichten, Updates und Trendanalyse
- Nutzen Sie die Leistungsfähigkeit der Benchmark-Analyse für eine umfassende Konkurrenzverfolgung
Inhaltsverzeichnis
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET: GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7 DBMR VENDOR SHARE ANALYSIS
2.8 MULTIVARIATE MODELING
2.9 PRODUCTS LIFELINE CURVE
2.1 SECONDARY SOURCES
2.11 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.1.1 INCREASING GERIATRIC FEMALE POPULATION
3.1.2 INCREASING NUMBER OF INFECTIOUS AND CHRONIC DISEASES
3.1.3 INCREASING INVESTMENTS IN THE RESEARCH AND DEVELOPMENTAL ACTIVITIES
3.1.4 GROWING NUMBER OF DIAGNOSTIC DEVICE MANUFACTURING COMPANIES
3.2 RESTRAINTS
3.2.1 PRODUCT RECALLS OF VARIOUS COMPANIES
3.2.2 HIGH COST OF DIAGNOSTIC PRODUCTS
3.3 OPPORTUNITIES
3.3.1 TECHNOLOGICAL ADVANCEMENTS IN THE DIAGNOSTIC EQUIPMENT
3.3.2 STRATEGIC INITIATIVES BY VARIOUS COMPANIES
3.4 CHALLENGES
3.4.1 UNACCEPTABLE HEALTH DISPARITIES IN THE U.S.
3.4.2 PRICING PRESSURE
3.4.3 INCREASING ADOPTION OF REFURBISHED DIAGNOSTIC IMAGING SYSTEMS
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
6 EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES
6.1 OVERVIEW
6.2 IMAGING AND MONITORING SYSTEMS
6.2.1 MAMMOGRAPHY SYSTEMS
6.2.1.1 DEVICES
6.2.1.1.1 DIGITAL MAMMOGRAPHY SYSTEMS
6.2.1.1.2 BREAST TOMOSYNTHESIS
6.2.1.1.3 ANALOG MAMMOGRAPHY SYSTEMS
6.2.1.2 APPLICATIONS
6.2.1.2.1 BREAST LUMPS OR TUMORS
6.2.1.2.2 BREAST CANCER
6.2.1.2.3 OTHERS
6.2.2 ULTRASOUND IMAGING SYSTEMS
6.2.2.1 DEVICES
6.2.2.1.1 OB/GYN ULTRASOUND
6.2.2.1.2 BREAST ULTRASOUND
6.2.2.2 APPLICATIONS
6.2.2.2.1 PREGNANCY SCAN
6.2.2.2.1.1 FETAL DEVELOPMENT
6.2.2.2.1.2 FETAL ABNORMALITIES
6.2.2.2.1.3 OTHERS
6.2.2.2.2 PELVIC SCAN
6.2.2.2.2.1 ABNORMAL PERIODS
6.2.2.2.2.2 CYSTS
6.2.2.2.2.3 FIBROIDS
6.2.2.2.2.4 OTHERS
6.2.2.2.3 ABDOMINAL SCAN
6.2.2.2.4 OTHERS
6.2.2.2.4.1 BREAST SCANS
6.2.2.2.4.2 MUSCULOSKELETAL SCANS
6.2.2.2.4.3 INTERNAL STRUCTURES
6.2.3 MRI SYSTEMS
6.2.3.1 APPLICATIONS
6.2.3.1.1 BREAST SCAN
6.2.3.1.2 ABDOMEN SCAN
6.2.3.1.3 JOINTS SCAN
6.2.3.1.4 SPINAL CORD SCAN
6.2.3.1.5 CARDIAC SCAN
6.2.3.1.6 BLOOD VESSELS SCAN
6.2.3.1.7 OTHERS
6.2.4 FERTILITY MONITORS
6.2.4.1 APPLICATIONS
6.2.4.1.1 OVULATION
6.2.4.1.2 INFERTILITY
6.2.4.1.3 PREGNANCY
6.2.4.1.4 HORMONAL IMBALANCE
6.2.4.1.5 OTHERS
6.2.5 BONE DENSITOMETER
6.2.5.1 APPLICATIONS
6.2.5.1.1 OSTEOPOROSIS
6.2.5.1.2 BONE-RELATED PROBLEMS
6.2.5.1.3 RHEUMATOID ARTHRITIS
6.2.6 NUCLEAR IMAGING SYSTEMS
6.2.6.1 APPLICATIONS
6.2.6.1.1 OSTEOARTHRITIS
6.2.6.1.2 HEART DISEASE
6.2.6.1.3 UROLOGICAL PROBLEMS
6.2.6.1.4 GYNECOLOGICAL CANCERS
6.2.6.1.5 MULTIPLE SCLEROSIS
6.2.6.1.6 ALZHEIMER’S DISEASE
6.2.6.1.7 THYROID DISEASE
6.2.6.1.8 SEXUALLY TRANSMITTED INFECTIONS
6.2.6.1.9 STROKE
6.2.6.1.10 POST-TRAUMATIC STRESS DISORDER (PTSD)
6.2.6.1.11 LUPUS
6.2.6.1.12 OTHERS
6.2.7 OTHERS
6.3 BIOPSY DEVICES
6.3.1 BIOPSY FOR CANCER
6.3.1.1 BREAST CANCER
6.3.1.2 CERVICAL CANCER
6.3.1.3 OVARIAN CANCER
6.3.1.4 OTHERS
6.3.2 BREAST LUMPS BIOPSY
6.3.3 BLOOD BIOPSY
6.3.3.1 CANCEROUS
6.3.3.2 NON-CANCEROUS
6.3.4 LYMPH NODES BIOPSY
6.3.5 THYROID BIOPSY
6.3.6 SKIN BIOPSY
6.3.7 OTHERS
6.4 REAGENTS AND KITS
6.4.1 PREGNANCY AND FERTILITY TESTING KITS
6.4.1.1 PREGNANCY
6.4.1.2 OVULATION
6.4.1.3 OTHERS
6.4.2 BLOOD TEST TYPE KIT
6.4.2.1 OSTEOPOROSIS
6.4.2.2 BLOOD CHEMISTRY & BLOOD CELL COUNT
6.4.2.3 OTHERS
6.4.3 HEPATITIS TESTING KIT
6.4.4 TUMOR MARKER ELISA TEST KIT
6.4.5 STD TEST KITS
6.4.5.1 HIV TESTING
6.4.5.2 HUMAN PAPILLOMAVIRUS (HPV) TESTING
6.4.5.3 CHLAMYDIA TRACHOMATIS AND NEISSERIA GONORRHOEAE (CT/NG) TESTING
6.4.5.4 OTHERS
6.4.6 PAP SMEAR TEST KIT
6.4.7 MRSA TESTING KITS
6.4.8 HORMONE MARKERS ELISA KITS
6.4.9 TUBERCULOSIS TEST KIT
6.4.10 OTHERS
6.5 BIOMARKERS
6.5.1 ONCOLOGY
6.5.1.1 BREAST CANCER
6.5.1.2 CERVICAL CANCER
6.5.1.3 OVARIAN CANCER
6.5.1.4 OTHERS
6.5.2 PREGNANCY COMPLICATIONS
6.5.3 INFECTIOUS DISEASES
6.5.4 CARDIOVASCULAR DISEASES
6.5.5 OTHERS
6.6 OTHERS
7 EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET, BY END USER
7.1 OVERVIEW
7.2 HOSPITALS
7.3 DIAGNOSTIC AND IMAGING CENTERS
7.4 CLINICS
7.5 HOME CARE SETTING
8 EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET, BY GEOGRAPHY
8.1 EUROPE
8.1.1 GERMANY
8.1.2 FRANCE
8.1.3 U.K.
8.1.4 ITALY
8.1.5 SPAIN
8.1.6 RUSSIA
8.1.7 SWITZERLAND
8.1.8 NETHERLANDS
8.1.9 BELGIUM
8.1.10 TURKEY
8.1.11 REST OF EUROPE
9 EUROPE BIOPSY DEVICES IN WOMEN’S HEALTH DIAGNOSTICS MARKET, COMPANY LANDSCAPE
9.1 COMPANY SHARE ANALYSIS: EUROPE
10 EUROPE MAMMOGRAPHY SYSTEM IN WOMEN’S HEALTH DIAGNOSTICS MARKET, COMPANY LANDSCAPE
10.1 COMPANY SHARE ANALYSIS: EUROPE
11 EUROPE ULTRASONIC IMAGING SYSTEM IN WOMEN’S HEALTH DIAGNOSTICS MARKET, COMPANY LANDSCAPE
11.1 COMPANY SHARE ANALYSIS: EUROPE
12 EUROPE MRI SYSTEM IN WOMEN’S HEALTH DIAGNOSTICS MARKET, COMPANY LANDSCAPE
12.1 COMPANY SHARE ANALYSIS: EUROPE
13 COMPANY PROFILE
13.1 HOLOGIC INC
13.1.1 COMPANY SNAPSHOT
13.1.2 REVENUE ANALYSIS
13.1.3 COMPANY SHARE ANALYSIS
13.1.4 PRODUCT PORTFOLIO
13.1.5 RECENT DEVELOPMENTS
13.2 SIEMENS
13.2.1 COMPANY SNAPSHOT
13.2.2 REVENUE ANALYSIS
13.2.3 COMPANY SHARE ANALYSIS
13.2.4 PRODUCT PORTFOLIO
13.2.5 RECENT DEVELOPMENTS
13.3 GENERAL ELECTRIC
13.3.1 COMPANY SNAPSHOT
13.3.2 REVENUE ANALYSIS
13.3.3 COMPANY SHARE ANALYSIS
13.3.4 PRODUCT PORTFOLIO
13.3.5 RECENT DEVELOPMENT
13.4 KONINKLIJKE PHILIPS N.V.
13.4.1 COMPANY SNAPSHOT
13.4.2 REVENUE ANALYSIS
13.4.3 COMPANY SHARE ANALYSIS
13.4.4 PRODUCT PORTFOLIO
13.4.5 RECENT DEVELOPMENTS
13.5 HITACHI, LTD.
13.5.1 COMPANY SNAPSHOT
13.5.2 REVENUE ANALYSIS
13.5.3 COMPANY SHARE ANALYSIS
13.5.4 PRODUCT PORTFOLIO
13.5.5 RECENT DEVELOPMENTS
13.6 FUJIFILM HOLDINGS CORPORATION
13.6.1 COMPANY SNAPSHOT
13.6.2 REVENUE ANALYSIS
13.6.3 COMPANY SHARE ANALYSIS
13.6.4 PRODUCT PORTFOLIO
13.6.5 RECENT DEVELOPMENTS
13.7 ABBOTT
13.7.1 COMPANY SNAPSHOT
13.7.2 REVENUE ANALYSIS
13.7.3 PRODUCT PORTFOLIO
13.7.4 RECENT DEVELOPMENTS
13.8 BD
13.8.1 COMPANY SNAPSHOT
13.8.2 REVENUE ANALYSIS
13.8.3 PRODUCT PORTFOLIO
13.8.4 RECENT DEVELOPMENTS
13.9 BIOMERIEUX SA
13.9.1 COMPANY SNAPSHOT
13.9.2 REVENUE ANALYSIS
13.9.3 PRODUCT PORTFOLIO
13.9.4 RECENT DEVELOPMENT
13.1 BIOMERIEUX SA
13.10.1 COMPANY SNAPSHOT
13.10.2 REVENUE ANALYSIS
13.10.3 PRODUCT PORTFOLIO
13.10.4 RECENT DEVELOPMENT
13.11 CANON INC.
13.11.1 COMPANY SNAPSHOT
13.11.2 REVENUE ANALYSIS
13.11.3 PRODUCT PORTFOLIO
13.11.4 RECENT DEVELOPMENTS
13.12 CARDINAL HEALTH
13.12.1 COMPANY SNAPSHOT
13.12.2 REVENUE ANALYSIS
13.12.3 PRODUCT PORTFOLIO
13.12.4 RECENT DEVELOPMENT
13.13 CARESTREAM HEALTH
13.13.1 COMPANY SNAPSHOT
13.13.2 PRODUCT PORTFOLIO
13.13.3 RECENT DEVELOPMENT
13.14 COOK
13.14.1 COMPANY SNAPSHOT
13.14.2 DIVISION PORTFOLIO
13.14.3 RECENT DEVELOPMENTS
13.15 DANAHER
13.15.1 COMPANY SNAPSHOT
13.15.2 REVENUE ANALYSIS
13.15.3 PRODUCT PORTFOLIO
13.15.4 RECENT DEVELOPMENTS
13.16 F. HOFFMANN-LA ROCHE LTD.
13.16.1 COMPANY SNAPSHOT
13.16.2 REVENUE ANALYSIS
13.16.3 PRODUCT PORTFOLIO
13.16.4 RECENT DEVELOPMENTS
13.17 MEDGYN PRODUCTS, INC
13.17.1 COMPANY SNAPSHOT
13.17.2 PRODUCT PORTFOLIO
13.17.3 RECENT DEVELOPMENT
13.18 NEUROLOGICA CORP.
13.18.1 COMPANY SNAPSHOT
13.18.2 PRODUCT PORTFOLIO
13.18.3 RECENT DEVELOPMENTS
13.19 PERKINELMER INC.
13.19.1 COMPANY SNAPSHOT
13.19.2 REVENUE ANALYSIS
13.19.3 PRODUCT PORTFOLIO
13.19.4 RECENT DEVELOPMENT
13.2 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
13.20.1 COMPANY SNAPSHOT
13.20.2 PRODUCT PORTFOLIO
13.20.3 RECENT DEVELOPMENTS
13.21 SHIMADZU CORPORATION
13.21.1 COMPANY SNAPSHOT
13.21.2 REVENUE ANALYSIS
13.21.3 PRODUCT PORTFOLIO
13.21.4 RECENT DEVELOPEMNT
13.22 SYSMEX CORPORATION
13.22.1 COMPANY SNAPSHOT
13.22.2 REVENUE ANALYSIS
13.22.3 PRODUCT PORTFOLIO
13.22.4 RECENT DEVELOPMENT
13.23 THERMO FISHER SCIENTIFIC INC.
13.23.1 COMPANY SNAPSHOT
13.23.2 REVENUE ANALYSIS
13.23.3 PRODUCT PORTFOLIO
13.23.4 RECENT DEVELOPMENTS
13.24 URIT MEDICAL ELECTRONIC CO., LTD
13.24.1 COMPANY SNAPSHOT
13.24.2 PRODUCT PORTFOLIO
13.24.3 RECENT DEVELOPMENT
14 CONCLUSION
15 SWOT ANALYSIS AND DBMR ANALYSIS
15.1 SWOT ANALYSIS
15.2 DATA BRIDGE MARKET RESEARCH ANALYSIS
16 QUESTIONNAIRE
17 RELATED REPORTS
Tabellenverzeichnis
TABLE 1 RESEARCH AND DEVELOPMENT (USD MILLION)
TABLE 2 EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 3 EUROPE IMAGING AND MONITORING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 4 EUROPE IMAGING AND MONITORING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 5 EUROPE MAMMOGRAPHY SYSTEMS DEVICES IN WOMEN’S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTICS DEVICE, 2017-2026 (USD MILLION)
TABLE 6 EUROPE APPLICATIONS OF MAMMOGRAPHY SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTICS DEVICE , 2017-2026 (USD MILLION)
TABLE 7 EUROPE ULTRASOUND IMAGING SYSTEMS DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTICS DEVICE , 2017-2026 (USD MILLION)
TABLE 8 EUROPE APPLICATIONS OF ULTRASOUND IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTICS DEVICE , 2017-2026 (USD MILLION)
TABLE 9 EUROPE PREGNANCY SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY APPLICATIONS, 2017-2026 (USD MILLION)
TABLE 10 EUROPE PELVIC SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY APPLICATIONS, 2017-2026 (USD MILLION)
TABLE 11 EUROPE OTHERS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY APPLICATIONS, 2017-2026 (USD MILLION)
TABLE 12 EUROPE APPLICATIONS OF MRI SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTICS DEVICES, 2017-2026 (USD MILLION)
TABLE 13 EUROPE APPLICATIONS OF FERTILITY MONITORS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTICS DEVICES , 2017-2026 (USD MILLION)
TABLE 14 EUROPE BONE DENSITOMETER APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTICS DEVICES, 2017-2026 (USD MILLION)
TABLE 15 EUROPE APPLICATIONS OF NUCLEAR IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTICS DEVICES , 2017-2026 (USD MILLION)
TABLE 16 EUROPE BIOPSY DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 17 EUROPE BIOPSY DEVICES APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTICS DEVICES, 2017-2026 (USD MILLION)
TABLE 18 EUROPE BIOPSY FOR CANCER IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTICS DEVICES , 2017-2026 (USD MILLION)
TABLE 19 EUROPE BLOOD BIOPSY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTICS DEVICES, 2017-2026 (USD MILLION)
TABLE 20 EUROPE REAGENTS AND KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 21 EUROPE REAGENTS AND KITS IN WOMEN’S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 22 EUROPE PREGNANCY AND FERTILITY TESTING KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 23 EUROPE BLOOD TEST TYPE KIT IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 24 EUROPE STD TEST KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 25 EUROPE BIOMARKERS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 26 EUROPE BIOMARKERS APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTICS DEVICES, 2017-2026 (USD MILLION)
TABLE 27 EUROPE ONCOLOGY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTICS DEVICES , 2017-2026 (USD MILLION)
TABLE 28 EUROPE OTHERS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 29 EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 30 EUROPE HOSPITALS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 31 EUROPE DIAGNOSTIC AND IMAGING CENTERS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 32 EUROPE CLINICS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 33 EUROPE HOME CARE SETTING IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 34 EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET, BY COUNTRY, 2017-2026 (USD MILLION)
TABLE 35 EUROPE WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 36 EUROPE IMAGING AND MONITORING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 37 EUROPE MAMMOGRAPHY SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 38 EUROPE APPLICATIONS OF MAMMOGRAPHY SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 39 EUROPE ULTRASOUND IMAGING SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 40 EUROPE APPLICATIONS OF ULTRASOUND IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 41 EUROPE PREGNANCY SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 42 EUROPE PELVIC SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 43 EUROPE OTHERS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 44 EUROPE APPLICATIONS OF NUCLEAR IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 45 EUROPE APPLICATIONS OF MRI SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 46 EUROPE APPLICATIONS OF FERTILITY MONITORS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 47 EUROPE BONE DENSITOMETER APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 48 EUROPE BIOPSY DEVICES APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 49 EUROPE BLOOD BIOPSY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 50 EUROPE BIOPSY FOR CANCER IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 51 EUROPE BIOMARKERS APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 52 EUROPE ONCOLOGY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 53 EUROPE REAGENTS AND KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 54 EUROPE PREGNANCY AND FERTILITY TESTING KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 55 EUROPE BLOOD TEST TYPE KIT IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 56 EUROPE STD TEST KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 57 EUROPE WOMEN'S HEALTH DIAGNOSTICS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 58 GERMANY WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 59 GERMANY IMAGING AND MONITORING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 60 GERMANY MAMMOGRAPHY SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 61 GERMANY APPLICATIONS OF MAMMOGRAPHY SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 62 GERMANY ULTRASOUND IMAGING SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 63 GERMANY APPLICATIONS OF ULTRASOUND IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 64 GERMANY PREGNANCY SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 65 GERMANY PELVIC SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 66 GERMANY OTHERS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 67 GERMANY APPLICATIONS OF NUCLEAR IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 68 GERMANY APPLICATIONS OF MRI SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 69 GERMANY APPLICATIONS OF FERTILITY MONITORS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 70 GERMANY BONE DENSITOMETER APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 71 GERMANY BIOPSY DEVICES APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 72 GERMANY BLOOD BIOPSY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 73 GERMANY BIOPSY FOR CANCER IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 74 GERMANY BIOMARKERS APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 75 GERMANY ONCOLOGY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 76 GERMANY REAGENTS AND KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 77 GERMANY PREGNANCY AND FERTILITY TESTING KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 78 GERMANY BLOOD TEST TYPE KIT IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 79 GERMANY STD TEST KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 80 GERMANY WOMEN'S HEALTH DIAGNOSTICS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 81 FRANCE WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 82 FRANCE IMAGING AND MONITORING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 83 FRANCE MAMMOGRAPHY SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 84 FRANCE APPLICATIONS OF MAMMOGRAPHY SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 85 FRANCE ULTRASOUND IMAGING SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 86 FRANCE APPLICATIONS OF ULTRASOUND IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 87 FRANCE PREGNANCY SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 88 FRANCE PELVIC SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 89 FRANCE OTHERS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 90 FRANCE APPLICATIONS OF NUCLEAR IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 91 FRANCE APPLICATIONS OF MRI SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 92 FRANCE APPLICATIONS OF FERTILITY MONITORS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 93 FRANCE BONE DENSITOMETER APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 94 FRANCE BIOPSY DEVICES APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 95 FRANCE BLOOD BIOPSY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 96 FRANCE BIOPSY FOR CANCER IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 97 FRANCE BIOMARKERS APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 98 FRANCE ONCOLOGY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 99 FRANCE REAGENTS AND KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 100 FRANCE PREGNANCY AND FERTILITY TESTING KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 101 FRANCE BLOOD TEST TYPE KIT IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 102 FRANCE STD TEST KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 103 FRANCE WOMEN'S HEALTH DIAGNOSTICS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 104 U.K. WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 105 U.K. IMAGING AND MONITORING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 106 U.K. MAMMOGRAPHY SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 107 U.K. APPLICATIONS OF MAMMOGRAPHY SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 108 U.K. ULTRASOUND IMAGING SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 109 U.K. APPLICATIONS OF ULTRASOUND IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 110 U.K. PREGNANCY SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 111 U.K. PELVIC SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 112 U.K. OTHERS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 113 U.K. APPLICATIONS OF NUCLEAR IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 114 U.K. APPLICATIONS OF MRI SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 115 U.K. APPLICATIONS OF FERTILITY MONITORS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 116 U.K. BONE DENSITOMETER APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 117 U.K. BIOPSY DEVICES APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 118 U.K. BLOOD BIOPSY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 119 U.K. BIOPSY FOR CANCER IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 120 U.K. BIOMARKERS APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 121 U.K. ONCOLOGY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 122 U.K. REAGENTS AND KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 123 U.K. PREGNANCY AND FERTILITY TESTING KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 124 U.K. BLOOD TEST TYPE KIT IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 125 U.K. STD TEST KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 126 U.K. WOMEN'S HEALTH DIAGNOSTICS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 127 ITALY WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 128 ITALY IMAGING AND MONITORING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 129 ITALY MAMMOGRAPHY SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 130 ITALY APPLICATIONS OF MAMMOGRAPHY SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 131 ITALY ULTRASOUND IMAGING SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 132 ITALY APPLICATIONS OF ULTRASOUND IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 133 ITALY PREGNANCY SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 134 ITALY PELVIC SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 135 ITALY OTHERS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 136 ITALY APPLICATIONS OF NUCLEAR IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 137 ITALY APPLICATIONS OF MRI SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 138 ITALY APPLICATIONS OF FERTILITY MONITORS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 139 ITALY BONE DENSITOMETER APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 140 ITALY BIOPSY DEVICES APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 141 ITALY BLOOD BIOPSY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 142 ITALY BIOPSY FOR CANCER IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 143 ITALY BIOMARKERS APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 144 ITALY ONCOLOGY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 145 ITALY REAGENTS AND KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 146 ITALY PREGNANCY AND FERTILITY TESTING KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 147 ITALY BLOOD TEST TYPE KIT IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 148 ITALY STD TEST KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 149 ITALY WOMEN'S HEALTH DIAGNOSTICS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 150 SPAIN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 151 SPAIN IMAGING AND MONITORING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 152 SPAIN MAMMOGRAPHY SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 153 SPAIN APPLICATIONS OF MAMMOGRAPHY SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 154 SPAIN ULTRASOUND IMAGING SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 155 SPAIN APPLICATIONS OF ULTRASOUND IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 156 SPAIN PREGNANCY SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 157 SPAIN PELVIC SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 158 SPAIN OTHERS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 159 SPAIN APPLICATIONS OF NUCLEAR IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 160 SPAIN APPLICATIONS OF MRI SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 161 SPAIN APPLICATIONS OF FERTILITY MONITORS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 162 SPAIN BONE DENSITOMETER APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 163 SPAIN BIOPSY DEVICES APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 164 SPAIN BLOOD BIOPSY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 165 SPAIN BIOPSY FOR CANCER IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 166 SPAIN BIOMARKERS APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 167 SPAIN ONCOLOGY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 168 SPAIN REAGENTS AND KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 169 SPAIN PREGNANCY AND FERTILITY TESTING KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 170 SPAIN BLOOD TEST TYPE KIT IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 171 SPAIN STD TEST KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 172 SPAIN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 173 RUSSIA WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 174 RUSSIA IMAGING AND MONITORING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 175 RUSSIA MAMMOGRAPHY SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 176 RUSSIA APPLICATIONS OF MAMMOGRAPHY SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 177 RUSSIA ULTRASOUND IMAGING SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 178 RUSSIA APPLICATIONS OF ULTRASOUND IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 179 RUSSIA PREGNANCY SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 180 RUSSIA PELVIC SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 181 RUSSIA OTHERS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 182 RUSSIA APPLICATIONS OF NUCLEAR IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 183 RUSSIA APPLICATIONS OF MRI SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 184 RUSSIA APPLICATIONS OF FERTILITY MONITORS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 185 RUSSIA BONE DENSITOMETER APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 186 RUSSIA BIOPSY DEVICES APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 187 RUSSIA BLOOD BIOPSY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 188 RUSSIA BIOPSY FOR CANCER IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 189 RUSSIA BIOMARKERS APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 190 RUSSIA ONCOLOGY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 191 RUSSIA REAGENTS AND KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 192 RUSSIA PREGNANCY AND FERTILITY TESTING KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 193 RUSSIA BLOOD TEST TYPE KIT IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 194 RUSSIA STD TEST KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 195 RUSSIA WOMEN'S HEALTH DIAGNOSTICS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 196 SWITZERLAND WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 197 SWITZERLAND IMAGING AND MONITORING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 198 SWITZERLAND MAMMOGRAPHY SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 199 SWITZERLAND APPLICATIONS OF MAMMOGRAPHY SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 200 SWITZERLAND ULTRASOUND IMAGING SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 201 SWITZERLAND APPLICATIONS OF ULTRASOUND IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 202 SWITZERLAND PREGNANCY SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 203 SWITZERLAND PELVIC SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 204 SWITZERLAND OTHERS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 205 SWITZERLAND APPLICATIONS OF NUCLEAR IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 206 SWITZERLAND APPLICATIONS OF MRI SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 207 SWITZERLAND APPLICATIONS OF FERTILITY MONITORS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 208 SWITZERLAND BONE DENSITOMETER APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 209 SWITZERLAND BIOPSY DEVICES APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 210 SWITZERLAND BLOOD BIOPSY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 211 SWITZERLAND BIOPSY FOR CANCER IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 212 SWITZERLAND BIOMARKERS APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 213 SWITZERLAND ONCOLOGY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 214 SWITZERLAND REAGENTS AND KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 215 SWITZERLAND PREGNANCY AND FERTILITY TESTING KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 216 SWITZERLAND BLOOD TEST TYPE KIT IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 217 SWITZERLAND STD TEST KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 218 SWITZERLAND WOMEN'S HEALTH DIAGNOSTICS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 219 NETHERLANDS WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 220 NETHERLANDS IMAGING AND MONITORING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 221 NETHERLANDS MAMMOGRAPHY SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 222 NETHERLANDS APPLICATIONS OF MAMMOGRAPHY SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 223 NETHERLANDS ULTRASOUND IMAGING SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 224 NETHERLANDS APPLICATIONS OF ULTRASOUND IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 225 NETHERLANDS PREGNANCY SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 226 NETHERLANDS PELVIC SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 227 NETHERLANDS OTHERS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 228 NETHERLANDS APPLICATIONS OF NUCLEAR IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 229 NETHERLANDS APPLICATIONS OF MRI SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 230 NETHERLANDS APPLICATIONS OF FERTILITY MONITORS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 231 NETHERLANDS BONE DENSITOMETER APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 232 NETHERLANDS BIOPSY DEVICES APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 233 NETHERLANDS BLOOD BIOPSY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 234 NETHERLANDS BIOPSY FOR CANCER IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 235 NETHERLANDS BIOMARKERS APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 236 NETHERLANDS ONCOLOGY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 237 NETHERLANDS REAGENTS AND KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 238 NETHERLANDS PREGNANCY AND FERTILITY TESTING KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 239 NETHERLANDS BLOOD TEST TYPE KIT IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 240 NETHERLANDS STD TEST KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 241 NETHERLANDS WOMEN'S HEALTH DIAGNOSTICS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 242 BELGIUM WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 243 BELGIUM IMAGING AND MONITORING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 244 BELGIUM MAMMOGRAPHY SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 245 BELGIUM APPLICATIONS OF MAMMOGRAPHY SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 246 BELGIUM ULTRASOUND IMAGING SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 247 BELGIUM APPLICATIONS OF ULTRASOUND IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 248 BELGIUM PREGNANCY SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 249 BELGIUM PELVIC SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 250 BELGIUM OTHERS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 251 BELGIUM APPLICATIONS OF NUCLEAR IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 252 BELGIUM APPLICATIONS OF MRI SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 253 BELGIUM APPLICATIONS OF FERTILITY MONITORS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 254 BELGIUM BONE DENSITOMETER APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 255 BELGIUM BIOPSY DEVICES APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 256 BELGIUM BLOOD BIOPSY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 257 BELGIUM BIOPSY FOR CANCER IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 258 BELGIUM BIOMARKERS APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 259 BELGIUM ONCOLOGY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 260 BELGIUM REAGENTS AND KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 261 BELGIUM PREGNANCY AND FERTILITY TESTING KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 262 BELGIUM BLOOD TEST TYPE KIT IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 263 BELGIUM STD TEST KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 264 BELGIUM WOMEN'S HEALTH DIAGNOSTICS MARKET, BY END USER, 2017-2026 (USD MILLION
TABLE 265 TURKEY WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 266 TURKEY IMAGING AND MONITORING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 267 TURKEY MAMMOGRAPHY SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 268 TURKEY APPLICATIONS OF MAMMOGRAPHY SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 269 TURKEY ULTRASOUND IMAGING SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 270 TURKEY APPLICATIONS OF ULTRASOUND IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 271 TURKEY PREGNANCY SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 272 TURKEY PELVIC SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 273 TURKEY OTHERS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 274 TURKEY APPLICATIONS OF NUCLEAR IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 275 TURKEY APPLICATIONS OF MRI SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 276 TURKEY APPLICATIONS OF FERTILITY MONITORS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 277 TURKEY BONE DENSITOMETER APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 278 TURKEY BIOPSY DEVICES APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 279 TURKEY BLOOD BIOPSY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 280 TURKEY BIOPSY FOR CANCER IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 281 TURKEY BIOMARKERS APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)\
TABLE 282 TURKEY ONCOLOGY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 283 TURKEY REAGENTS AND KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 284 TURKEY PREGNANCY AND FERTILITY TESTING KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 285 TURKEY BLOOD TEST TYPE KIT IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 286 TURKEY STD TEST KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 287 TURKEY WOMEN'S HEALTH DIAGNOSTICS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 288 REST OF EUROPE WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
Abbildungsverzeichnis
FIGURE 1 EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET: SEGMENTATION
FIGURE 2 EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET: DATA VALIDATION MODEL
FIGURE 3 EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET: DROC ANALYSIS
FIGURE 4 EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET: EUROPE VS REGIONAL ANALYSIS
FIGURE 5 EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 EUROPE BIOPSY DEVICES IN WOMEN’S HEALTH DIAGNOSTICS MARKET: DBMR VENDOR SHARE ANALYSIS
FIGURE 8 EUROPE MAMMOGRAPHY SYSTEM IN WOMEN’S HEALTH DIAGNOSTICS MARKET: DBMR VENDOR SHARE ANALYSIS
FIGURE 9 EUROPE ULTRASONIC IMAGING SYSTEM IN WOMEN’S HEALTH DIAGNOSTICS MARKET: DBMR VENDOR SHARE ANALYSIS
FIGURE 10 EUROPE MRI SYSTEM IN WOMEN’S HEALTH DIAGNOSTICS MARKET: DBMR VENDOR SHARE ANALYSIS
FIGURE 11 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGE OF EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET
FIGURE 12 PERCENT DISTRIBUTION OF THE 10 LEADING CAUSES OF DEATH IN WOMEN: UNITED STATES, 2017
FIGURE 13 EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET: SEGMENTATION
FIGURE 14 INCREASING NUMBER OF INFECTIOUS AND CHRONIC DISEASES AND INCREASING INVESTMENTS IN THE RESEARCH AND DEVELOPMENTAL ACTIVITIES ARE EXPECTED TO DRIVE THE EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET IN THE FORECAST PERIOD OF 2019 TO 2026
FIGURE 15 IMAGING AND MONTORING IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET IN THE FORECAST PERIOD OF 2019 TO 2026
FIGURE 16 EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET: BY DIAGNOSTIC DEVICES, 2018
FIGURE 17 EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET: BY END USER, 2018
FIGURE 18 EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET: SNAPSHOT (2018)
FIGURE 19 EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET: BY COUNTRY (2018)
FIGURE 20 EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET: BY COUNTRY (2019 & 2026)
FIGURE 21 EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET: BY COUNTRY (2018 & 2026)
FIGURE 22 EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET: BY DIAGNOSTIC DEVICES (2019-2026)
FIGURE 23 EUROPE BIOPSY DEVISE IN WOMEN’S HEALTH DIAGNOSTICS MARKET: COMPANY SHARE 2018 (%)
FIGURE 24 EUROPE MAMMOGRAPHY SYSTEM IN WOMEN’S HEALTH DIAGNOSTICS MARKET: COMPANY SHARE 2018 (%)
FIGURE 25 EUROPE ULTRASONIC IMAGING SYSTEM IN WOMEN’S HEALTH DIAGNOSTICS MARKET: COMPANY SHARE 2018 (%)
FIGURE 26 EUROPE MRI SYSTEM IN WOMEN’S HEALTH DIAGNOSTICS MARKET: COMPANY SHARE 2018 (%)
Forschungsmethodik
Die Datenerfassung und Basisjahresanalyse werden mithilfe von Datenerfassungsmodulen mit großen Stichprobengrößen durchgeführt. Die Phase umfasst das Erhalten von Marktinformationen oder verwandten Daten aus verschiedenen Quellen und Strategien. Sie umfasst die Prüfung und Planung aller aus der Vergangenheit im Voraus erfassten Daten. Sie umfasst auch die Prüfung von Informationsinkonsistenzen, die in verschiedenen Informationsquellen auftreten. Die Marktdaten werden mithilfe von marktstatistischen und kohärenten Modellen analysiert und geschätzt. Darüber hinaus sind Marktanteilsanalyse und Schlüsseltrendanalyse die wichtigsten Erfolgsfaktoren im Marktbericht. Um mehr zu erfahren, fordern Sie bitte einen Analystenanruf an oder geben Sie Ihre Anfrage ein.
Die wichtigste Forschungsmethodik, die vom DBMR-Forschungsteam verwendet wird, ist die Datentriangulation, die Data Mining, die Analyse der Auswirkungen von Datenvariablen auf den Markt und die primäre (Branchenexperten-)Validierung umfasst. Zu den Datenmodellen gehören ein Lieferantenpositionierungsraster, eine Marktzeitlinienanalyse, ein Marktüberblick und -leitfaden, ein Firmenpositionierungsraster, eine Patentanalyse, eine Preisanalyse, eine Firmenmarktanteilsanalyse, Messstandards, eine globale versus eine regionale und Lieferantenanteilsanalyse. Um mehr über die Forschungsmethodik zu erfahren, senden Sie eine Anfrage an unsere Branchenexperten.
Anpassung möglich
Data Bridge Market Research ist ein führendes Unternehmen in der fortgeschrittenen formativen Forschung. Wir sind stolz darauf, unseren bestehenden und neuen Kunden Daten und Analysen zu bieten, die zu ihren Zielen passen. Der Bericht kann angepasst werden, um Preistrendanalysen von Zielmarken, Marktverständnis für zusätzliche Länder (fordern Sie die Länderliste an), Daten zu klinischen Studienergebnissen, Literaturübersicht, Analysen des Marktes für aufgearbeitete Produkte und Produktbasis einzuschließen. Marktanalysen von Zielkonkurrenten können von technologiebasierten Analysen bis hin zu Marktportfoliostrategien analysiert werden. Wir können so viele Wettbewerber hinzufügen, wie Sie Daten in dem von Ihnen gewünschten Format und Datenstil benötigen. Unser Analystenteam kann Ihnen auch Daten in groben Excel-Rohdateien und Pivot-Tabellen (Fact Book) bereitstellen oder Sie bei der Erstellung von Präsentationen aus den im Bericht verfügbaren Datensätzen unterstützen.
